Cathay Biotech Inc (688065) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Cathay Biotech Inc (688065) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-66.22 Million ≈ $-9.69 Million USD) by net assets (CN¥21.22 Billion ≈ $3.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cathay Biotech Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Cathay Biotech Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Cathay Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cathay Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cathay Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Walsin Lihwa Corp TW:1605	0.021x
InnoDisk TWO:5289	-0.172x
Fomento de Construcciones y Contratas SA MC:FCC	0.035x
LYFT Inc NASDAQ:LYFT	0.102x
Sigma Foods, S.A.B. de C.V. MX:SIGMAFA	0.362x
Warehouses de Pauw Comm VA BR:WDP	0.020x
Etsy, Inc. NASDAQ:ETSY	-0.197x
Marathon Digital Holdings Inc NASDAQ:MARA	-0.106x

Annual Cash Flow Conversion Efficiency for Cathay Biotech Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Cathay Biotech Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Cathay Biotech Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥15.10 Billion ≈ $2.21 Billion	CN¥820.93 Million ≈ $120.13 Million	0.054x	+41.03%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥569.45 Million ≈ $83.33 Million	0.039x	-27.87%
2022-12-31	CN¥15.04 Billion ≈ $2.20 Billion	CN¥803.67 Million ≈ $117.60 Million	0.053x	+32.10%
2021-12-31	CN¥14.69 Billion ≈ $2.15 Billion	CN¥594.18 Million ≈ $86.95 Million	0.040x	-9.78%
2020-12-31	CN¥11.48 Billion ≈ $1.68 Billion	CN¥514.96 Million ≈ $75.36 Million	0.045x	-42.12%
2019-12-31	CN¥4.64 Billion ≈ $679.25 Million	CN¥359.62 Million ≈ $52.62 Million	0.077x	+2477.46%
2018-12-31	CN¥3.16 Billion ≈ $461.93 Million	CN¥-10.29 Million ≈ $-1.51 Million	-0.003x	-113.39%
2017-12-31	CN¥2.20 Billion ≈ $321.46 Million	CN¥53.45 Million ≈ $7.82 Million	0.024x	+123.05%
2016-12-31	CN¥1.22 Billion ≈ $178.35 Million	CN¥-128.67 Million ≈ $-18.83 Million	-0.106x	--

About Cathay Biotech Inc

SHG:688065 China Chemicals

Market Cap

$5.26 Billion

CN¥35.95 Billion CNY

Market Cap Rank

#3487 Global

#523 in China

Share Price

CN¥49.84

Change (1 day)

-0.72%

52-Week Range

CN¥40.22 - CN¥62.24

All Time High

CN¥134.07